Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Gralla, M. Lichinitser, S. Vegt, H. Sleeboom, J. Mezger, C. Peschel, G. Tonini, R. Labianca, A. Macciocchi, M. Aapro (2003)
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron.Annals of oncology : official journal of the European Society for Medical Oncology, 14 10
R. Navari, L. Einhorn, S. Passik, P. Loehrer, Cynthia Johnson, M. Mayer, J. McClean, J. Vinson, W. Pletcher (2005)
A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier Oncology Group studySupportive Care in Cancer, 13
G. Gonullu, S. Demircan, M. Demirağ, D. Erdem, I. Yucel (2012)
Electrocardiographic findings of palonosetron in cancer patientsSupportive Care in Cancer, 20
R. Stoltz, J. Cyong, Ajit Shah, S. Parisi (2004)
Pharmacokinetic and Safety Evaluation of Palonosetron, a 5‐Hydroxytryptamine‐3 Receptor Antagonist, in U.S. and Japanese Healthy SubjectsThe Journal of Clinical Pharmacology, 44
R. Wender (2009)
Do current antiemetic practices result in positive patient outcomes? Results of a new study.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 66 1 Suppl 1
Xiaorong Dong, Jing Huang, Ru-bo Cao, Li Liu (2011)
Palonosetron for prevention of acute and delayed nausea and vomiting in non-small-cell lung carcinoma patientsMedical Oncology, 28
Zhou Likun, Jing Xiang, B. Yi, Duan Xin, Z. Tao (2011)
A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults.The oncologist, 16 2
R. Navari (2003)
Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.The journal of supportive oncology, 1 2
C. Rojas, A. Thomas, J. Alt, M. Stathis, Jie Zhang, E. Rubenstein, S. Sebastiani, S. Cantoreggi, B. Slusher (2010)
Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function.European journal of pharmacology, 626 2-3
K. Ho, T. Gan (2006)
Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomitingCurrent Opinion in Anaesthesiology, 19
M. Constenla (2004)
5-HT3 Receptor Antagonists for Prevention of Late Acute-Onset EmesisAnnals of Pharmacotherapy, 38
R. Dersimonian, R. Dersimonian, N. Laird, N. Laird (1986)
Meta-analysis in clinical trials.Controlled clinical trials, 7 3
K. Jordan, A. Hinke, A. Grothey, W. Voigt, D. Arnold, H. Wolf, H. Schmoll (2007)
A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesisSupportive Care in Cancer, 15
Zhaocai Yu, Wen-chao Liu, Ling Wang, Houjie Liang, Ying Huang, X. Si, He-long Zhang, Du-hu Liu, Hongmei Zhang (2008)
The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trialSupportive Care in Cancer, 17
M. Musso, R. Scalone, V. Bonanno, A. Crescimanno, V. Polizzi, F. Porretto, C. Bianchini, T. Perrone (2009)
Palonosetron (Aloxi®) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapySupportive Care in Cancer, 17
Bernardo (2009)
Palonosetron compared to ondansetron in the prevention of chemotherapy-induced nausea and vomiting: activity, safety, and cost-effectiveness evaluationJournal of Clinical Oncology, 27
S. Grunberg, R. Deuson, P. Mavros, O. Geling, M. Hansen, G. Cruciani, B. Daniele, G. Pouvourville, E. Rubenstein, G. Daugaard (2004)
Incidence of chemotherapy‐induced nausea and emesis after modern antiemeticsCancer, 100
W. Tian, Zhiqiang Wang, Juntian Zhou, Shucai Zhang, Jinghui Wang, Qiang Chen, Cheng Huang, L. Pan, Lili Zhang, Jian-jin Huang, Hong Shen, T. Lin (2011)
Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese populationMedical Oncology, 28
P. Eisenberg, F. Mackintosh, P. Ritch, P. Cornett, A. Macciocchi (2004)
Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical study.Annals of oncology : official journal of the European Society for Medical Oncology, 15 2
G. Mattiuzzi, J. Cortes, D. Blamble, B. Bekele, Lianchun Xiao, M. Cabanillas, G. Borthakur, S. O'brien, H. Kantarjian (2010)
Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy‐induced nausea and vomiting in patients with acute myelogenous leukemiaCancer, 116
L. Schwartzberg, G. Morrow, S. Balu, C. Craver, J. Gayle, D. Cox (2011)
Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United StatesCurrent Medical Research and Opinion, 27
M. Hamadani, A. Awab, L. Chaudhary, A. Tfayli (2006)
Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 12 2
D. Osoba, B. Zee, D. Warr, J. Latreille, L. Kaizer, J. Pater (1997)
Effect of postchemotherapy nausea and vomiting on health-related quality of lifeSupportive Care in Cancer, 5
M. Aapro, S. Grunberg, G. Manikhas, G. Olivares, T. Suarez, S. Tjulandin, L. Bertoli, F. Yunus, B. Morrica, Florian Lordick, A. Macciocchi (2006)
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.Annals of oncology : official journal of the European Society for Medical Oncology, 17 9
J. Kaushal, M. Gupta, V. Kaushal, G. Bhutani, R. Dhankar, R. Atri, S. Verma (2010)
Clinical evaluation of two antiemetic combinations palonosetron dexamethasone versus ondansetron dexamethasone in chemotherapy of head and neck cancer.Singapore medical journal, 51 11
M. Saito, K. Aogi, I. Sekine, H. Yoshizawa, Y. Yanagita, H. Sakai, Kenichi Inoue, C. Kitagawa, T. Ogura, S. Mitsuhashi (2009)
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.The Lancet. Oncology, 10 2
M. Watcha (2002)
Postoperative nausea and emesis.Anesthesiology clinics of North America, 20 3
Hamadani (2006)
Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapyJournal of Oncology Pharmacy Practice, 12
H. Gao, Y. Liang, N. Zhou, D. Zhang, H. Wu (2013)
Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy‐induced nausea and vomiting in patients receiving multiple‐day cisplatin chemotherapyInternal Medicine Journal, 43
A. Sepúlveda-Vildósola, Yadira Betanzos-Cabrera, Graciela Lastiri, H. Rivera-Márquez, M. Villasís-Keever, Volkmar Angel, F. Diaz, E. López-Aguilar (2008)
Palonosetron hydrochloride is an effective and safe option to prevent chemotherapy-induced nausea and vomiting in children.Archives of medical research, 39 6
P. Eisenberg, J. Figueroa-Vadillo, R. Zamora, V. Charu, J. Hajdenberg, A. Cartmell, A. Macciocchi, S. Grunberg (2003)
Improved prevention of moderately emetogenic chemotherapy‐induced nausea and vomiting with palonosetron, a pharmacologically novel 5‐HT3 receptor antagonistCancer, 98
M. Maemondo, N. Masuda, I. Sekine, K. Kubota, Y. Segawa, M. Shibuya, F. Imamura, N. Katakami, T. Hida, S. Takeo (2009)
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy.Annals of oncology : official journal of the European Society for Medical Oncology, 20 11
JIN Y., SUN W., GU D., YANG J., XU Z. & CHEN J. (2013) European Journal of Cancer Care22, 41–50
European Journal of Cancer Care – Wiley
Published: Jan 1, 2013
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.